{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:19:10Z","timestamp":1770448750519,"version":"3.49.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"DOI":"10.1186\/s44158-025-00336-w","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:25:17Z","timestamp":1767950717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Refractory septic shock: our updated pragmatic approach"],"prefix":"10.1186","volume":"6","author":[{"given":"Filippo","family":"Palmesino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Woodman-Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraser","family":"Hanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Wyncoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"1","key":"336_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2144-4","volume":"22","author":"P Nandhabalan","year":"2018","unstructured":"Nandhabalan P, Ioannou N, Meadows C, Wyncoll D (2018) Refractory septic shock: our pragmatic approach. Crit Care 22(1):215. https:\/\/doi.org\/10.1186\/s13054-018-2144-4","journal-title":"Crit Care"},{"key":"336_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"336_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154258","volume":"75","author":"E Antonucci","year":"2023","unstructured":"Antonucci E, Polo T, Giovini M et al (2023) Refractory septic shock and alternative wordings: a systematic review of literature. J Crit Care 154258. https:\/\/doi.org\/10.1016\/j.jcrc.2023.154258","journal-title":"J Crit Care"},{"issue":"3","key":"336_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2023.101193","volume":"42","author":"M Leone","year":"2023","unstructured":"Leone M, Einav S, Antonucci E et al (2023) Multimodal strategy to counteract vasodilation in septic shock. Anaesth Crit Care Pain Med 101193. https:\/\/doi.org\/10.1016\/j.accpm.2023.101193","journal-title":"Anaesth Crit Care Pain Med"},{"key":"336_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000006003","author":"PM Wieruszewski","year":"2023","unstructured":"Wieruszewski PM, Sevransky JE, Roberts RJ (2023) Is it time to reconsider the concept of \u201csalvage therapy\u201d in refractory shock? Crit Care Med. https:\/\/doi.org\/10.1097\/CCM.0000000000006003","journal-title":"Crit Care Med"},{"issue":"1","key":"336_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04446-1","volume":"27","author":"PM Wieruszewski","year":"2023","unstructured":"Wieruszewski PM, Bellomo R, Busse LW et al (2023) Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial. Crit Care 175. https:\/\/doi.org\/10.1186\/s13054-023-04446-1","journal-title":"Crit Care"},{"key":"336_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.3046","author":"A Kalimouttou","year":"2025","unstructured":"Kalimouttou A, Kennedy JN, Feng J et al (2025) Optimal vasopressin initiation in septic shock: the OVISS reinforcement learning study. JAMA. https:\/\/doi.org\/10.1001\/jama.2025.3046","journal-title":"JAMA"},{"key":"336_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305727","author":"P Caironi","year":"2014","unstructured":"Caironi P, Tognoni G, Masson S et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1305727","journal-title":"N Engl J Med"},{"issue":"10","key":"336_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016736","volume":"7","author":"N Heming","year":"2017","unstructured":"Heming N, Elatrous S, Jaber S et al (2017) Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open 7(10):e016736. https:\/\/doi.org\/10.1136\/bmjopen-2017-016736","journal-title":"BMJ Open"},{"issue":"5","key":"336_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00134-018-5075-2","volume":"44","author":"G Hariri","year":"2018","unstructured":"Hariri G, Joffre J, Deryckere S et al (2018) Albumin infusion improves endothelial function in septic shock patients: a pilot study. Intensive Care Med 44(5):669\u2013671. https:\/\/doi.org\/10.1007\/s00134-018-5075-2","journal-title":"Intensive Care Med"},{"issue":"1","key":"336_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99198-z","volume":"15","author":"L Jin","year":"2025","unstructured":"Jin L, Li Z, Qian J, Liao W, Xu F (2025) Comparative efficacy and prognostic impact of continuous versus intermittent hydrocortisone administration in septic shock patients. Sci Rep 15(1):14339. https:\/\/doi.org\/10.1038\/s41598-025-99198-z","journal-title":"Sci Rep"},{"issue":"9","key":"336_CR12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C et al (2018) Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 378(9):809\u2013818. https:\/\/doi.org\/10.1056\/NEJMoa1705716","journal-title":"N Engl J Med"},{"issue":"12","key":"336_CR13","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/s00134-024-07616-z","volume":"50","author":"J Walsham","year":"2024","unstructured":"Walsham J, Hammond N, Blumenthal A et al (2024) Fludrocortisone dose\u2013response relationship in septic shock: a randomised phase II trial. Intensive Care Med 50(12):2050\u20132060. https:\/\/doi.org\/10.1007\/s00134-024-07616-z","journal-title":"Intensive Care Med"},{"issue":"1","key":"336_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-025-03388-1","volume":"25","author":"L Ruyuan","year":"2025","unstructured":"Ruyuan L, Zhangshun S, Hongling L, Jianling S (2025) Corticosteroids for sepsis and septic shock: a meta-analysis of 18 RCTs with dose-stratified and fludrocortisone subgroup evaluation. BMC Anesthesiol 25(1):511. https:\/\/doi.org\/10.1186\/s12871-025-03388-1","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"336_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","volume":"35","author":"LK Barrett","year":"2007","unstructured":"Barrett LK, Singer M, Clapp LH (2007) Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 35(1):33\u201340. https:\/\/doi.org\/10.1097\/01.CCM.0000251127.45385.CD","journal-title":"Crit Care Med"},{"issue":"5","key":"336_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509. https:\/\/doi.org\/10.1001\/jama.2016.10485","journal-title":"JAMA"},{"key":"336_CR17","doi-asserted-by":"publisher","unstructured":"Russell JA, H\u00e9bert PC, Granton JT, Ayers D (2008) Vasopressin versus norepinephrine infusion in patients with septic shock.\u00a0N Engl J Med 358(9):877\u2013887. https:\/\/doi.org\/10.1056\/NEJMoa067373","DOI":"10.1056\/NEJMoa067373"},{"issue":"1","key":"336_CR18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/01.ccm.0000810708.23191.69","volume":"50","author":"G Korkames","year":"2022","unstructured":"Korkames G, Brink H, Peitz G (2022) 1096: effect of norepinephrine versus vasopressin on pulmonary artery pressure. Crit Care Med 50(1):546. https:\/\/doi.org\/10.1097\/01.ccm.0000810708.23191.69","journal-title":"Crit Care Med"},{"key":"336_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00594","volume":"11","author":"M Carrara","year":"2020","unstructured":"Carrara M, Herpain A, Baselli G, Ferrario M (2020) Vascular decoupling in septic shock: the combined role of autonomic nervous system, arterial stiffness, and peripheral vascular tone. Front Physiol 11:594. https:\/\/doi.org\/10.3389\/fphys.2020.00594","journal-title":"Front Physiol"},{"issue":"1","key":"336_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12975-y","volume":"12","author":"H Wisanusattra","year":"2022","unstructured":"Wisanusattra H, Khwannimit B (2022) Agreements between mean arterial pressure from radial and femoral artery measurements in refractory shock patients. Sci Rep 12(1):8825. https:\/\/doi.org\/10.1038\/s41598-022-12975-y","journal-title":"Sci Rep"},{"key":"336_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2010.09.006","author":"MA Fr\u00f6lich","year":"2011","unstructured":"Fr\u00f6lich MA, Arabshahi A, Katholi C, Prasain J, Barnes S (2011) Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteers. J Clin Anesth. https:\/\/doi.org\/10.1016\/j.jclinane.2010.09.006","journal-title":"J Clin Anesth"},{"issue":"6","key":"336_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bja.2021.06.048","volume":"127","author":"L Meng","year":"2021","unstructured":"Meng L (2021) Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review. Br J Anaesth 127(6):845\u2013861. https:\/\/doi.org\/10.1016\/j.bja.2021.06.048","journal-title":"Br J Anaesth"},{"issue":"5","key":"336_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10877-015-9768-6","volume":"30","author":"AF Erdem","year":"2016","unstructured":"Erdem AF, Kayabasoglu G, Tas Tuna A, Palabiyik O, Tomak Y, Beyaz SG (2016) Effect of controlled hypotension on regional cerebral oxygen saturation during rhinoplasty: a prospective study. J Clin Monit Comput 30(5):655\u2013660. https:\/\/doi.org\/10.1007\/s10877-015-9768-6","journal-title":"J Clin Monit Comput"},{"issue":"5","key":"336_CR24","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/00000539-200111000-00009","volume":"93","author":"D Andel","year":"2001","unstructured":"Andel D, Andel H, H\u00f6rauf K, Felfernig D, Millesi W, Zimpfer M (2001) The influence of deliberate hypotension on splanchnic perfusion balance with use of either isoflurane or esmolol and nitroglycerin. Anesth Analg 93(5):1116\u20131120. https:\/\/doi.org\/10.1097\/00000539-200111000-00009","journal-title":"Anesth Analg"},{"issue":"10","key":"336_CR25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jama.2020.0930","volume":"323","author":"F Lamontagne","year":"2020","unstructured":"Lamontagne F, Richards-Belle A, Thomas K et al (2020) Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA 323(10):938. https:\/\/doi.org\/10.1001\/jama.2020.0930","journal-title":"JAMA"},{"key":"336_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04255-y","volume":"26","author":"D De Backer","year":"2022","unstructured":"De Backer D, Cecconi M, Chew MS et al (2022) A plea for personalization of the hemodynamic management of septic shock. Crit Care 26:372. https:\/\/doi.org\/10.1186\/s13054-022-04255-y","journal-title":"Crit Care"},{"issue":"6","key":"336_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jcrc.2012.08.002","volume":"27","author":"C Enrico","year":"2012","unstructured":"Enrico C, Kanoore Edul VS, Vazquez AR et al (2012) Systemic and microcirculatory effects of dobutamine in patients with septic shock. J Crit Care 27(6):630\u2013638. https:\/\/doi.org\/10.1016\/j.jcrc.2012.08.002","journal-title":"J Crit Care"},{"issue":"6","key":"336_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1056\/NEJMoa2026845","volume":"385","author":"R Mathew","year":"2021","unstructured":"Mathew R, Santo PD, Jung RG et al (2021) Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med 385(6):516\u2013525. https:\/\/doi.org\/10.1056\/NEJMoa2026845","journal-title":"N Engl J Med"},{"issue":"1","key":"336_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2484464","volume":"57","author":"S Tongyoo","year":"2025","unstructured":"Tongyoo S, Chobngam S, Yolsiriwat N, Jiranakorn C (2025) Effects of adjunctive milrinone versus placebo on hemodynamics in patients with septic shock: a randomized controlled trial. Ann Med 57(1):2484464. https:\/\/doi.org\/10.1080\/07853890.2025.2484464","journal-title":"Ann Med"},{"key":"336_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1520596","volume":"11","author":"X Du","year":"2025","unstructured":"Du X, Xiong F, Hou Y, Yu X, Pan P (2025) Levosimendan for sepsis-induced myocardial dysfunction: friend or foe? Front Cardiovasc Med 11:1520596. https:\/\/doi.org\/10.3389\/fcvm.2024.1520596","journal-title":"Front Cardiovasc Med"},{"issue":"17","key":"336_CR31","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","volume":"375","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Perkins GD, Singer M et al (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375(17):1638\u20131648. https:\/\/doi.org\/10.1056\/NEJMoa1609409","journal-title":"N Engl J Med"},{"issue":"2","key":"336_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/CCM.0000000000001572","volume":"44","author":"MW Donnino","year":"2016","unstructured":"Donnino MW, Andersen LW, Chase M et al (2016) Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Crit Care Med 44(2):360\u2013367. https:\/\/doi.org\/10.1097\/CCM.0000000000001572","journal-title":"Crit Care Med"},{"issue":"9","key":"336_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bjae.2019.05.005","volume":"19","author":"AME de Spoelstra- Man","year":"2019","unstructured":"de Spoelstra- Man AME, van Oudemans- Straaten HM, Elbers PWG (2019) Vitamin C and thiamine in critical illness. BJA Educ 19(9):290\u2013296. https:\/\/doi.org\/10.1016\/j.bjae.2019.05.005","journal-title":"BJA Educ"},{"issue":"1","key":"336_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58115-2","volume":"10","author":"M Ostermann","year":"2020","unstructured":"Ostermann M, Summers J, Lei K et al (2020) <article-title update=\"added\">Micronutrients in critically ill patients with severe acute kidney injury \u2013 a prospective study. Sci Rep 10(1):1505. https:\/\/doi.org\/10.1038\/s41598-020-58115-2","journal-title":"Sci Rep"},{"issue":"1","key":"336_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0896-7","volume":"19","author":"A Kimmoun","year":"2015","unstructured":"Kimmoun A, Novy E, Auchet T, Ducrocq N, Levy B (2015) Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside. Crit Care 19(1):175. https:\/\/doi.org\/10.1186\/s13054-015-0896-7","journal-title":"Crit Care"},{"issue":"22","key":"336_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.20231","volume":"334","author":"B Jung","year":"2025","unstructured":"Jung B, Jabaudon M, De Jong A et al (2025) Sodium bicarbonate for severe metabolic acidemia and acute kidney injury: the BICARICU-2 randomized clinical trial. JAMA e2520231. https:\/\/doi.org\/10.1001\/jama.2025.20231","journal-title":"JAMA"},{"issue":"3","key":"336_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/EC9.0000000000000077","volume":"4","author":"S Huang","year":"2024","unstructured":"Huang S, Peng Y, Zhang X, Yao Y, Feng C (2024) Early sodium bicarbonate therapy for critically ill patients with septic shock and acute moderate metabolic acidosis. Emerg Crit Care Med 4(3):101\u2013102. https:\/\/doi.org\/10.1097\/EC9.0000000000000077","journal-title":"Emerg Crit Care Med"},{"issue":"4","key":"336_CR38","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/ALN.0000000000000077","volume":"120","author":"A Kimmoun","year":"2014","unstructured":"Kimmoun A, Strub C (2014) Efficient extra- and intracellular alkalinization improves cardiovascular functions in severe lactic acidosis induced by hemorrhagic shock. Anesthesiology 120(4):926\u2013934. https:\/\/doi.org\/10.1097\/ALN.0000000000000077","journal-title":"Anesthesiology"},{"issue":"4","key":"336_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.ajkd.2016.02.049","volume":"68","author":"JT Park","year":"2016","unstructured":"Park JT, Lee H, Kee YK et al (2016) High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial. Am J Kidney Dis 68(4):599\u2013608. https:\/\/doi.org\/10.1053\/j.ajkd.2016.02.049","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"336_CR40","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","volume":"39","author":"O Joannes-Boyau","year":"2013","unstructured":"Joannes-Boyau O, Honor\u00e9 PM, Perez P et al (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 39(9):1535\u20131546. https:\/\/doi.org\/10.1007\/s00134-013-2967-z","journal-title":"Intensive Care Med"},{"issue":"1","key":"336_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13243-9","volume":"12","author":"G Yu","year":"2022","unstructured":"Yu G, Cheng K, Liu Q, Wu W, Hong H, Lin X (2022) Clinical outcomes of severe sepsis and septic shock patients with left ventricular dysfunction undergoing continuous renal replacement therapy. Sci Rep 12(1):9360. https:\/\/doi.org\/10.1038\/s41598-022-13243-9","journal-title":"Sci Rep"},{"issue":"4","key":"336_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00134-019-05544-x","volume":"45","author":"D De Backer","year":"2019","unstructured":"De Backer D, Cecconi M, Lipman J et al (2019) Challenges in the management of septic shock: a narrative review. Intensive Care Med 45(4):420\u2013433. https:\/\/doi.org\/10.1007\/s00134-019-05544-x","journal-title":"Intensive Care Med"},{"issue":"11","key":"336_CR43","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.44.11.754","volume":"44","author":"JS Mohrland","year":"1985","unstructured":"Mohrland JS, Porter JM, Smith EA, Belch J, Simms MH (1985) A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud\u2019s syndrome. Ann Rheum Dis 44(11):754\u2013760. https:\/\/doi.org\/10.1136\/ard.44.11.754","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"336_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/22423982.2023.2189552","volume":"82","author":"J Gauthier","year":"2023","unstructured":"Gauthier J, Morris-Janzen D, Poole A (2023) Iloprost for the treatment of frostbite: a scoping review. Int J Circumpolar Health 82(1):2189552. https:\/\/doi.org\/10.1080\/22423982.2023.2189552","journal-title":"Int J Circumpolar Health"},{"issue":"1","key":"336_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2573-8","volume":"23","author":"RE Berthelsen","year":"2019","unstructured":"Berthelsen RE, Ostrowski SR, Bestle MH, Johansson PI (2019) Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)\u2014a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy. Crit Care 23(1):301. https:\/\/doi.org\/10.1186\/s13054-019-2573-8","journal-title":"Crit Care"},{"issue":"9","key":"336_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.32444","volume":"7","author":"MH Bestle","year":"2024","unstructured":"Bestle MH, Stensballe J, Lange T et al (2024) Iloprost and organ dysfunction in adults with septic shock and endotheliopathy: a randomized clinical trial. JAMA Netw Open 7(9):e2432444. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.32444","journal-title":"JAMA Netw Open"},{"issue":"7","key":"336_CR47","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1164\/rccm.202410-1924OC","volume":"211","author":"M Legrand","year":"2025","unstructured":"Legrand M, Jullien E, Kimmoun A et al (2025) Iloprost for the treatment of severe septic shock with persistent hypoperfusion: a double-blind, randomized controlled trial. Am J Respir Crit Care Med 211(7):1211\u20131219. https:\/\/doi.org\/10.1164\/rccm.202410-1924OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"336_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJM198708133170701","volume":"317","author":"D Bihari","year":"1987","unstructured":"Bihari D, Smithies M, Gimson A, Tinker J (1987) The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 317(7):397\u2013403. https:\/\/doi.org\/10.1056\/NEJM198708133170701","journal-title":"N Engl J Med"},{"issue":"3","key":"336_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/cc13932","volume":"18","author":"A Lima","year":"2014","unstructured":"Lima A, Van Genderen ME, Van Bommel J, Klijn E, Jansem T, Bakker J (2014) Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock. Crit Care 18(3):R126. https:\/\/doi.org\/10.1186\/cc13932","journal-title":"Crit Care"},{"issue":"1","key":"336_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05123-7","volume":"28","author":"M Legrand","year":"2024","unstructured":"Legrand M, Khanna AK, Ostermann M et al (2024) The renin\u2013angiotensin\u2013aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II. Crit Care 28(1):389. https:\/\/doi.org\/10.1186\/s13054-024-05123-7","journal-title":"Crit Care"},{"issue":"5","key":"336_CR51","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377(5):419\u2013430. https:\/\/doi.org\/10.1056\/NEJMoa1704154","journal-title":"N Engl J Med"},{"issue":"1","key":"336_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/j.jvca.2023.09.037","volume":"38","author":"A Pruna","year":"2024","unstructured":"Pruna A, Bonaccorso A, Belletti A et al (2024) Methylene blue reduces mortality in critically ill and perioperative patients: a meta-analysis of randomized trials. J Cardiothorac Vasc Anesth 38(1):268\u2013274. https:\/\/doi.org\/10.1053\/j.jvca.2023.09.037","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"7","key":"336_CR53","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001110","volume":"6","author":"SM Fernando","year":"2024","unstructured":"Fernando SM, Tran A, Soliman K et al (2024) Methylene blue in septic shock: a systematic review and meta-analysis. Crit Care Explor 6(7):e1110. https:\/\/doi.org\/10.1097\/CCE.0000000000001110","journal-title":"Crit Care Explor"},{"issue":"11","key":"336_CR54","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1139\/cjpp-2017-0074","volume":"95","author":"OM Duicu","year":"2017","unstructured":"Duicu OM, Privistirescu A, Wolf A et al (2017) Methylene blue improves mitochondrial respiration and decreases oxidative stress in a substrate-dependent manner in diabetic rat hearts. Can J Physiol Pharmacol 95(11):1376\u20131382. https:\/\/doi.org\/10.1139\/cjpp-2017-0074","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"336_CR55","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4103\/0970-9185.74599","volume":"26","author":"PR Ginimuge","year":"2010","unstructured":"Ginimuge PR, Jyothi SD (2010) Methylene blue: revisited. J Anaesthesiol Clin Pharmacol 26(4):517\u2013520","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"2","key":"336_CR56","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.chest.2022.09.021","volume":"163","author":"JJ Patel","year":"2023","unstructured":"Patel JJ, Willoughby R, Peterson J et al (2023) High-dose IV hydroxocobalamin (vitamin B12) in septic shock. Chest 163(2):303\u2013312. https:\/\/doi.org\/10.1016\/j.chest.2022.09.021","journal-title":"Chest"},{"key":"336_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkae081","volume":"13","author":"Y Kotani","year":"2025","unstructured":"Kotani Y, Ryan N, Udy AA, Fujii T (2025) Haemodynamic management of septic shock. Burns Trauma 13:tkae081. https:\/\/doi.org\/10.1093\/burnst\/tkae081","journal-title":"Burns Trauma"},{"issue":"8","key":"336_CR58","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1053\/j.jvca.2023.03.017","volume":"37","author":"J Ortoleva","year":"2023","unstructured":"Ortoleva J, Shapeton AD (2023) Seeing red: hydroxocobalamin and result interference. J Cardiothorac Vasc Anesth 37(8):1339\u20131342. https:\/\/doi.org\/10.1053\/j.jvca.2023.03.017","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"336_CR59","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1128\/AAC.47.5.1752-1755.2003","volume":"47","author":"EA Coyle","year":"2003","unstructured":"Coyle EA, Cha R, Rybak MJ (2003) Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin A release. Antimicrob Agents Chemother 47(5):1752\u20131755. https:\/\/doi.org\/10.1128\/AAC.47.5.1752-1755.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"336_CR60","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1473-3099(20)30523-5","volume":"21","author":"A Babiker","year":"2021","unstructured":"Babiker A, Li X, Lai YL et al (2021) Effectiveness of adjunctive clindamycin in \u03b2-lactam antibiotic-treated patients with invasive \u03b2-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Lancet Infect Dis 21(5):697\u2013710. https:\/\/doi.org\/10.1016\/S1473-3099(20)30523-5","journal-title":"Lancet Infect Dis"},{"key":"336_CR61","doi-asserted-by":"publisher","unstructured":"Campbell AJ, Dotel R, Blyth CC, Davis JS, Tong SYC, Bowen AC. Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal. J Antimicrob Chemother. Published online October 10, 2018. https:\/\/doi.org\/10.1093\/jac\/dky387","DOI":"10.1093\/jac\/dky387"},{"issue":"1","key":"336_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.femsim.2005.01.001","volume":"44","author":"R Nau","year":"2005","unstructured":"Nau R, Eiffert H (2005) Minimizing the release of proinflammatory and toxic bacterial products within the host: a promising approach to improve outcome in life-threatening infections. FEMS Immunol Med Microbiol 44(1):1\u201316. https:\/\/doi.org\/10.1016\/j.femsim.2005.01.001","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"9","key":"336_CR63","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/cid\/ciy401","volume":"67","author":"T Parks","year":"2018","unstructured":"Parks T, Wilson C, Curtis N, Norrby-Teglund A, Sriskandan S (2018) Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis. Clin Infect Dis 67(9):1434\u20131436. https:\/\/doi.org\/10.1093\/cid\/ciy401","journal-title":"Clin Infect Dis"},{"issue":"1","key":"336_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04592-8","volume":"21","author":"B Pan","year":"2023","unstructured":"Pan B, Sun P, Pei R, Lin F, Cao H (2023) Efficacy of IVIG therapy for patients with sepsis: a systematic review and meta-analysis. J Transl Med 21(1):765. https:\/\/doi.org\/10.1186\/s12967-023-04592-8","journal-title":"J Transl Med"},{"issue":"2","key":"336_CR65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/SHK.0000000000001519","volume":"54","author":"M Peetermans","year":"2020","unstructured":"Peetermans M, Wan RYY, Camporota L, Barrett NA, Retter A (2020) Use of intravenous immunoglobulins in patients with suspected toxin-mediated shock requiring extracorporeal membrane oxygenation. Shock 54(2):209\u2013212. https:\/\/doi.org\/10.1097\/SHK.0000000000001519","journal-title":"Shock"},{"issue":"10250","key":"336_CR66","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(20)30733-9","volume":"396","author":"N Br\u00e9chot","year":"2020","unstructured":"Br\u00e9chot N, Hajage D, Kimmoun A et al (2020) Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study. Lancet 396(10250):545\u2013552. https:\/\/doi.org\/10.1016\/S0140-6736(20)30733-9","journal-title":"Lancet"},{"issue":"3","key":"336_CR67","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/CCM.0000000000000026","volume":"42","author":"EK Stevenson","year":"2014","unstructured":"Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ (2014) Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med 42(3):625\u2013631. https:\/\/doi.org\/10.1097\/CCM.0000000000000026","journal-title":"Crit Care Med"},{"issue":"1_suppl","key":"336_CR68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0267659118766833","volume":"33","author":"DJ Vogel","year":"2018","unstructured":"Vogel DJ, Murray J, Czapran AZ et al (2018) Veno-arterio-venous ECMO for septic cardiomyopathy: a single-centre experience. Perfusion 33(1_suppl):57\u201364. https:\/\/doi.org\/10.1177\/0267659118766833","journal-title":"Perfusion"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-025-00336-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-025-00336-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-025-00336-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:03:00Z","timestamp":1770390180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s44158-025-00336-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1186\/s44158-025-00336-w","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}